These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 21504366

  • 1. Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding.
    Kay HY, Kim WD, Hwang SJ, Choi HS, Gilroy RK, Wan YJ, Kim SG.
    Antioxid Redox Signal; 2011 Oct 15; 15(8):2135-46. PubMed ID: 21504366
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of LXRα-dependent steatosis and oxidative injury by liquiritigenin, a licorice flavonoid, as mediated with Nrf2 activation.
    Kim YW, Kim YM, Yang YM, Kay HY, Kim WD, Lee JW, Hwang SJ, Kim SG.
    Antioxid Redox Signal; 2011 Mar 01; 14(5):733-45. PubMed ID: 20677908
    [Abstract] [Full Text] [Related]

  • 3. Resveratrol inhibits LXRα-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction.
    Jin SH, Yang JH, Shin BY, Seo K, Shin SM, Cho IJ, Ki SH.
    Toxicol Appl Pharmacol; 2013 Aug 15; 271(1):95-105. PubMed ID: 23651738
    [Abstract] [Full Text] [Related]

  • 4. Ursodeoxycholic acid inhibits liver X receptor α-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE.
    Lee JM, Gang GT, Kim DK, Kim YD, Koo SH, Lee CH, Choi HS.
    J Biol Chem; 2014 Jan 10; 289(2):1079-91. PubMed ID: 24265317
    [Abstract] [Full Text] [Related]

  • 5. Histone H3K9 Demethylase JMJD2B Plays a Role in LXRα-Dependent Lipogenesis.
    Kim JH, Jung DY, Kim HR, Jung MH.
    Int J Mol Sci; 2020 Nov 05; 21(21):. PubMed ID: 33167594
    [Abstract] [Full Text] [Related]

  • 6. Oleanolic Acid Inhibits Liver X Receptor Alpha and Pregnane X Receptor to Attenuate Ligand-Induced Lipogenesis.
    Lin YN, Chang HY, Wang CCN, Chu FY, Shen HY, Chen CJ, Lim YP.
    J Agric Food Chem; 2018 Oct 24; 66(42):10964-10976. PubMed ID: 30351048
    [Abstract] [Full Text] [Related]

  • 7. Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones.
    Hwahng SH, Ki SH, Bae EJ, Kim HE, Kim SG.
    Hepatology; 2009 Jun 24; 49(6):1913-25. PubMed ID: 19378344
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis.
    Kim YW, Kim YM, Yang YM, Kim TH, Hwang SJ, Lee JR, Kim SC, Kim SG.
    Free Radic Biol Med; 2010 Feb 15; 48(4):567-78. PubMed ID: 20005944
    [Abstract] [Full Text] [Related]

  • 9. Cilostazol inhibits insulin-stimulated expression of sterol regulatory binding protein-1c via inhibition of LXR and Sp1.
    Jung YA, Kim HK, Bae KH, Seo HY, Kim HS, Jang BK, Jung GS, Lee IK, Kim MK, Park KG.
    Exp Mol Med; 2014 Jan 24; 46(1):e73. PubMed ID: 24458133
    [Abstract] [Full Text] [Related]

  • 10. Ursolic Acid, a Novel Liver X Receptor α (LXRα) Antagonist Inhibiting Ligand-Induced Nonalcoholic Fatty Liver and Drug-Induced Lipogenesis.
    Lin YN, Wang CCN, Chang HY, Chu FY, Hsu YA, Cheng WK, Ma WC, Chen CJ, Wan L, Lim YP.
    J Agric Food Chem; 2018 Nov 07; 66(44):11647-11662. PubMed ID: 30359008
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of liver X receptor-α-dependent hepatic steatosis by isoliquiritigenin, a licorice antioxidant flavonoid, as mediated by JNK1 inhibition.
    Kim YM, Kim TH, Kim YW, Yang YM, Ryu DH, Hwang SJ, Lee JR, Kim SC, Kim SG.
    Free Radic Biol Med; 2010 Dec 01; 49(11):1722-34. PubMed ID: 20840863
    [Abstract] [Full Text] [Related]

  • 12. 20(S)-protopanaxatriol inhibits liver X receptor α-mediated expression of lipogenic genes in hepatocytes.
    Oh GS, Yoon J, Lee GG, Oh WK, Kim SW.
    J Pharmacol Sci; 2015 Jun 01; 128(2):71-7. PubMed ID: 26109499
    [Abstract] [Full Text] [Related]

  • 13. Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRα-SREBP1c-dependent mechanism.
    Zhang X, Liu J, Su W, Wu J, Wang C, Kong X, Gustafsson JÅ, Ding J, Ma X, Guan Y.
    J Diabetes; 2014 May 01; 6(3):212-20. PubMed ID: 23945440
    [Abstract] [Full Text] [Related]

  • 14. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR.
    Cha JY, Repa JJ.
    J Biol Chem; 2007 Jan 05; 282(1):743-51. PubMed ID: 17107947
    [Abstract] [Full Text] [Related]

  • 15. Thyroid hormone-responsive SPOT 14 homolog promotes hepatic lipogenesis, and its expression is regulated by liver X receptor α through a sterol regulatory element-binding protein 1c-dependent mechanism in mice.
    Wu J, Wang C, Li S, Li S, Wang W, Li J, Chi Y, Yang H, Kong X, Zhou Y, Dong C, Wang F, Xu G, Yang J, Gustafsson JÅ, Guan Y.
    Hepatology; 2013 Aug 05; 58(2):617-28. PubMed ID: 23348573
    [Abstract] [Full Text] [Related]

  • 16. Curcumin regulates endogenous and exogenous metabolism via Nrf2-FXR-LXR pathway in NAFLD mice.
    Yan C, Zhang Y, Zhang X, Aa J, Wang G, Xie Y.
    Biomed Pharmacother; 2018 Sep 05; 105():274-281. PubMed ID: 29860219
    [Abstract] [Full Text] [Related]

  • 17. Relevance of FXR-p62/SQSTM1 pathway for survival and protection of mouse hepatocytes and liver, especially with steatosis.
    Haga S, Yimin, Ozaki M.
    BMC Gastroenterol; 2017 Jan 13; 17(1):9. PubMed ID: 28086800
    [Abstract] [Full Text] [Related]

  • 18. Regulation of hepatic fatty acid elongase 5 by LXRalpha-SREBP-1c.
    Qin Y, Dalen KT, Gustafsson JA, Nebb HI.
    Biochim Biophys Acta; 2009 Feb 13; 1791(2):140-7. PubMed ID: 19136075
    [Abstract] [Full Text] [Related]

  • 19. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
    Quinet EM, Savio DA, Halpern AR, Chen L, Schuster GU, Gustafsson JA, Basso MD, Nambi P.
    Mol Pharmacol; 2006 Oct 13; 70(4):1340-9. PubMed ID: 16825483
    [Abstract] [Full Text] [Related]

  • 20. Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR/LXRs-dependent manner.
    Han X, Cui ZY, Song J, Piao HQ, Lian LH, Hou LS, Wang G, Zheng S, Dong XX, Nan JX, Wu YL.
    Chem Biol Interact; 2019 Sep 25; 311():108794. PubMed ID: 31421115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.